CytomX Therapeutics (CTMX) Q3 Earnings and Revenues Top Estimates

CytomX Therapeutics (CTMX) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of$ 0.16 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 143.75%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.07 per share when it actually produced a loss of $0.08, delivering a surprise of -14.29%.Over the la ...